(Q39974732)

English

Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model.

scientific article

Statements

Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model. (English)
Guru Sonpavde
Weiguo Jian
Hao Liu
Meng-Fen Wu
Steven S Shen
Seth P Lerner
4 June 2008
391-399

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit